Ibuprofen Suspension
NDC Package 45802-952-26
Package Information
Ibuprofen suspension is ibuprofen is used to relieve pain from various conditions such as headache, dental pain, menstrual cramps, muscle aches, or arthritis. This formulation utilizes a suspension delivery system. Marketed by Padagis Israel Pharmaceuticals Ltd, this product is identified by NDC 45802-952 and is authorized under FDA application ANDA076925.
Identification & Billing
- RxCUI: 197803 - ibuprofen 100 MG in 5 mL Oral Suspension
- RxCUI: 197803 - ibuprofen 20 MG/ML Oral Suspension
- RxCUI: 197803 - ibuprofen 100 MG per 5 ML Oral Suspension
- RxCUI: 197803 - ibuprofen 200 MG per 10 ML Oral Suspension
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 45802 - Padagis Israel Pharmaceuticals Ltd
- 45802-952 - Ibuprofen
- 45802-952-26 - 1 BOTTLE in 1 CARTON / 120 mL in 1 BOTTLE
- 45802-952 - Ibuprofen
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (45802-952). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 45802-952-26 identifies a specific commercial package of 1 bottle in 1 carton / 120 ml in 1 bottle of Ibuprofen, a human prescription drug labeled by Padagis Israel Pharmaceuticals Ltd. This suspension is formulated for oral use and contains ibuprofen as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Padagis Israel Pharmaceuticals Ltd on December 08, 2004. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
Ibuprofen is used to relieve pain from various conditions such as headache, dental pain, menstrual cramps, muscle aches, or arthritis. It is also used to reduce fever and to relieve minor aches and pain due to the common cold or flu. Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID). It works by blocking your body's production of certain natural substances that cause inflammation. This effect helps to decrease swelling, pain, or fever. If you are treating a chronic condition such as arthritis, ask your doctor about non-drug treatments and/or using other medications to treat your pain. See also Warning section. Check the ingredients on the label even if you have used the product before. The manufacturer may have changed the ingredients. Also, products with similar names may contain different ingredients meant for different purposes. Taking the wrong product could harm you.
How is this Padagis Israel Pharmaceuticals Ltd product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 45802095226. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.